evolcSign inStart free
Menu

HumGel

Human tumor-derived cell matrix (MyoGel) for cancer research labs running invasion and drug-testing assays

Oulu, FinlandFounded 2026humgel.comWebsite technologies

+ Add to sales board

Highlights

  • Young companyFounded 2026
  • New on EvolcAdded 2026-10-28

About HumGel

HumGel makes MyoGel, a liquid extracellular matrix derived from human tumors, used as a growth substrate for cancer cell research. It is supplied in 1, 5 and 10 ml vials, as pre-coated 12-, 96- and 384-well plates, and in custom configurations for matrix density and format. The matrix is room-temperature stable and contains no animal-derived materials.

The product is used for scratch wound assays, spheroid invasion assays, high-throughput drug testing and 3D microfluidic chips. Its customers are researchers, clinicians and pharmaceutical companies. Products are sold against orders and quotes, with custom configurations quoted on request.

HumGel Oy was founded on 13 January 2026 and is based in Oulu, Finland. The company's product page cites published studies from 2015 to 2025 that use the matrix.

Product: MyoGel, a liquid human tumor-derived extracellular matrix sold as vials and pre-coated plates for cancer cell assays.

Jobs at HumGel

No open positions listed right now.

More biotech & pharma companies

  • KÄÄPÄ BioTech

    Standardised functional mushroom extracts for pharmaceutical, nutraceutical and wellness product developers
    Karjalohja, FinlandBiotech & pharmaFounded 2018
    New on Evolc

  • LignoSphere Company

    Colloidal lignin particles from kraft lignin for coating and adhesive manufacturers seeking fossil-free phenolic substitutes
    Espoo, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc

  • Linio Biotech

    Regenerative tissue platform (Tience) for skin and soft-tissue defect treatment, used by clinicians in the Nordics
    Helsinki, FinlandBiotech & pharmaFounded 2017
    New on Evolc

  • Medicortex Finland

    Develops biomarker-based diagnostic tests for traumatic brain injury and concussion
    Turku, FinlandBiotech & pharmaFounded 2014
    New on Evolc

  • Misvik Biology

    Cancer drug screening and preclinical research services for biopharma companies and academic institutions
    Turku, FinlandBiotech & pharmaFounded 2014
    New on Evolc

  • Nadmed

    NAD and glutathione assay kits and laboratory analysis for clinical and research laboratories
    Helsinki, FinlandBiotech & pharmaFounded 2022
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Apache